Expression of MHC class II antigens on human glioma cells modulated by transfection with genes encoding these antigens

Neurol Med Chir (Tokyo). 1991 Oct;31(10):623-8. doi: 10.2176/nmc.31.623.

Abstract

Four glioma cell lines not expressing human leukocyte antigen (HLA)-DR or DQ did so after transfection with genes encoding HLA-DR and DQ. The glioma cells had enhanced ability to stimulate allogeneic and autologous responding lymphocytes in the mixed lymphocyte response (MLR). Glioma cells expressing only HLA-DR had weaker MLR enhancement than those expressing both HLA-DR and DQ or only HLA-DQ. Stimulation by transformed glioma cells increased the killing activity of responding lymphocytes against autologous glioma cells 2.0 times. Both HLA-DR and DQ are important in MLR, and the immunogenicity of glioma cells might be increased by transfection with genes encoding these antigens.

MeSH terms

  • Antigens, Neoplasm / biosynthesis*
  • Brain Neoplasms / immunology
  • Brain Neoplasms / pathology*
  • Cytotoxicity Tests, Immunologic
  • Gene Expression Regulation, Neoplastic*
  • Glioma / immunology
  • Glioma / pathology*
  • HLA-DQ Antigens / biosynthesis*
  • HLA-DQ Antigens / genetics
  • HLA-DR Antigens / biosynthesis*
  • HLA-DR Antigens / genetics
  • Humans
  • Lymphocytes / immunology
  • Recombinant Proteins / biosynthesis
  • Transfection
  • Tumor Cells, Cultured / immunology

Substances

  • Antigens, Neoplasm
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • Recombinant Proteins